Revvity | PKI - Debt


Revvity reported $3.37B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Agilent USD 3.35B 55M Sep/2025
Align Technology USD 121.27M 1.75M Sep/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.4B 11.2M Sep/2025
Bruker USD 2.01B 426.8M Sep/2025
Celltrion KRW 171.09B 2.05T Jun/2025
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Dentsply International USD 2.48B 14M Sep/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Exact Sciences USD 2.34B 15.24M Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.58B 22M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
OraSure Technologies USD 782K 465K Jun/2024
Ovoca Bio EUR 0 0 Jun/2021
Pacific Biosciences Of California USD 892M 201K Sep/2023
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Quest Diagnostics USD 6.38B 2M Sep/2025
Quidel USD 2.84B 51.1M Sep/2025
Repligen USD 542.21M 146.65M Dec/2025
Revvity USD 3.37B 5.86M Sep/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Tilray USD 640.95M 35.17M Jun/2022
Waters USD 1.49B 52.2M Sep/2025
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025